These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7137535)

  • 1. The protective property of equipotent bronchodilating doses of inhaled KWD 2131 and terbutaline against allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N; Granerus G
    Allergy; 1982 Aug; 37(6):407-16. PubMed ID: 7137535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the protective effect of a new beta-agonist, KWD 2131, on allergen-induced bronchospasm.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Jul; 35(5):413-9. PubMed ID: 6108726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New beta-agonist, KWD 2131, compared with terbutaline in asthmatics. A cumulative dose-response study.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):105-12. PubMed ID: 6104451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):113-21. PubMed ID: 6104452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction.
    Hegardt B; Pauwels R; Van Der Straeten M
    Allergy; 1981 Feb; 36(2):115-22. PubMed ID: 6112931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
    Hegardt B; Arner B
    Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
    Pegelow KO; Strandberg K
    Allergy; 1980 Sep; 35(6):509-19. PubMed ID: 6110383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
    Wong CS; Wahedna I; Pavord ID; Tattersfield AE
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiallergic actions of high topical doses of terbutaline in human nasal airways.
    Svensson C; Greiff L; Andersson M; Alkner U; Grönneberg R; Persson CG
    Allergy; 1995 Nov; 50(11):884-90. PubMed ID: 8748720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
    Strandberg K; Pegelow KO; Persson CG; Sörenby L
    Allergy; 1979 Aug; 34(4):221-4. PubMed ID: 92896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist.
    Peebles RS; Permutt S; Togias A
    J Appl Physiol (1985); 1998 May; 84(5):1500-5. PubMed ID: 9572791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhaled diphemanil methylsulfate, a parasympatholytic agent, on histamine induced bronchoconstriction in asymptomatic asthmatics.
    Küng M; Diamond L
    Ann Allergy; 1984 Jan; 52(1):22-5. PubMed ID: 6696291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does theophylline potentiate inhaled beta 2-agonists?
    Svedmyr K; Svedmyr N
    Allergy; 1982 Feb; 37(2):101-10. PubMed ID: 6127963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of ipratropium bromide aerosol against bronchospasm induced by hyperventilation and the inhalation of allergen, methacholine and histamine.
    Clarke PS; Jarrett RG; Hall GJ
    Ann Allergy; 1982 Mar; 48(3):180-3. PubMed ID: 6461281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a beta-adrenoceptor stimulant, KWD 2131, in nasal histamine provocation tests. Rhinomanometric evaluations in normal persons and patients with hay fever.
    Svensson G; Hegardt B; Löfkvist T
    Acta Otolaryngol; 1981; 92(5-6):535-41. PubMed ID: 6171989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release.
    Martin GL; Atkins PC; Dunsky EH; Zweiman B
    J Allergy Clin Immunol; 1980 Sep; 66(3):204-12. PubMed ID: 7410745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-reported Symptoms after Induced and Inhibited Bronchoconstriction in Athletes.
    Simpson AJ; Romer LM; Kippelen P
    Med Sci Sports Exerc; 2015 Oct; 47(10):2005-13. PubMed ID: 25710876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.